Wondfo SARS-CoV-2 Antibody Test (lateral flow method)

Manufactured by Guangzhou Wondfo Biotech Co. Ltd., China - https://en.wondfo.com.cn/ 

Related Scientific Literature

• Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG
• Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
• Concordance between two rapid diagnostic tests for the detection of antibodies against SARS-CoV-2
• Genetics of Severe Acute Respiratory Syndrome Coronavirus-2 and Diagnosis of Coronavirus Disease-2019: An Overview
• Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey
• Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
• Comparison of various serological assays for novel SARS-COV-2
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
• Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2
• Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country
• Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting
• Sensitivity of the Wondfo One Step COVID-19 test using serum samples
• A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements